Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noblevast Advisory
Hong Kong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Noblevast Advisory is a specialized financial advisory firm based in Hong Kong that focuses on the life sciences, healthcare, and technology sectors. The company provides a range of corporate finance services, including initial public offering (IPO) advisory, mergers and acquisitions (M&A) support, and private placement execution. Noblevast Advisory is particularly active in the Hong Kong capital markets, frequently acting as a financial advisor or joint sponsor for biotechnology companies seeking listings under the HKEX Chapter 18A regulations. The firm bridges the gap between healthcare innovators and global investors by providing deep industry insights and regulatory navigation.
- Industry
- Consulting
Beyond the preview
Go deeper on Noblevast Advisory.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Noblevast Advisory.